
Formulary Search
You are here : Home > Formulary Search
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Search Results : Angina (Diltiazem hydrochloride - Angina)
Records returned : 21 (on 29 May 2025 at 12:57:20).
Return to search results for ' Angina '.
Show Icon and Status Keys Hide Icon and Status Keys
Icon Key
NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
Cancer Drugs Fund
ICB
Treatment commissioned by the ICB
Link to the NICE website

Low carbon device
Status Key
Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
See narrative
See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Green
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Prescribe by BRAND
Tildiem Retard (TWICE daily) are the lowest cost brand in Primary Care for patients requiring a tablet formulation.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Modified release capsules
Restrictions / Comments:
Important
Prescribe by BRAND
Angitil SR capsules (TWICE daily) or Zemtard XL or Slozem (ONCE daily) are the lowest cost brands for Primary Care.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Sublingual spray
- Sublingual tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Patches
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Red
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Modified release tablets
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
Twice daily (assymetric) dosing is recommended
Formulary Status :
Links :
Indication :
Status :
Green (see narrative)
Formulations :
- Modified release capsules
- Modified release tablets
Restrictions / Comments:
Important
Restricted to when isosorbide mononitrate standard release is not suitable.
Primary Care prescribers should follow local advice on the most cost-effective brands. OptimiseRx will be used to identify current recommendations.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Prescribe by BRAND.
Tensipine MR (Twice daily) and Adipine XL (once daily) are the preferred tablet brands.
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Modified release capsules
Restrictions / Comments:
Important
Prescribe by BRAND.
Coracten SR (Twice daily) and Coracten XL (once daily) are the preferred capsule brands.
Links :
Indication :
Status :
Green
Formulations :
- Modified release capsules
- Oral solution
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Green
Formulations :
- Modified release capsules
- Modified release tablets
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Green
Formulations :
- Oral solution
Restrictions / Comments:
Links :
Indication :
Status :
Blue
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted to cardiology. Specialist initiation and at least one month supply before transfer to primary care
Formulary Status :
Links :
Indication :
Status :
Amber
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Restricted to cardiology
Formulary Status :
Links :